Projects funded by the NCN
Improving therapeutic efficacy of anti-CD20 antibodies in precursor B-cell acute lymphoblastic leukemia
2019/35/B/NZ5/01428
Keywords:
acute lymphoblastic leukemia B cell CD20 therapy immunotherapy antibodies
Descriptors:
- NZ5_7: Human disease treatment
- NZ6_1: Adaptive and innate immunity
Panel:
NZ5 - Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution :
Warszawski Uniwersytet Medyczny, Wydzial Lekarski
woj. mazowieckie
Principal investigator (from the host institution):
Number of co-investigators in the project: 9
Call: OPUS 18 - announced on 2019-09-16
Amount awarded: 1 819 368 PLN
Project start date (Y-m-d): 2020-09-29
Project end date (Y-m-d): 2023-09-28
Project duration:: 36 months (the same as in the proposal)
Project status: Project completed
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.